- See how industry is navigating competing priorities
- Examine what is required to fuel growth under current market conditions
- Evaluate risk and determine how to compete for follow-on financing
- Building a Strategic Specialty Distribution Plan
- Establishing Agile Commercial Capabilities
- Evaluating Emerging GoToMarket Models
- Integrating Data Insights and Analytics into Brand Planning
- Excelling at Commercial Execution & Innovation
- Discuss how to fully leverage AI
- Discover keys to implementing commercial analytics
- Pinpoint new staffing priorities in risk environments while attracting talent and managing staffing priorities
- Move from in-person promotion to digital and recognize ways to reach doctors that reduce cost burdens
- Prioritize providing commercial insight and activity early (pre-phase 2)
- Break down silos between commercial and R&D
- Share commercial insights to improve decision making in product development
- Identify opportunities to align patient education with product value
- Improve patient adherence and treatment outcomes by involving patient advocacy and engagement earlier
- Identify and reflect the patient voice in commercialization strategy
- Steps to transforming into a digital-first ecosystem
- Discuss examples of using AI in commercial teams
- Connect HCPs with brands more effectively and efficiently
- Generate real time data for greater commercial insights
- Refocus your core organization methods around customer experience customer experience
- Leverage a digital-first perspective and an omnichannel approach to interact with customers
- Seamlessly incorporate insights about customers across the entire organization
Healthcare commercialization is at a time of unprecedented disruption. Patient populations are smaller and harder to find; HCPs are shifting interaction preferences and are harder to reach. At the same time, commercial organizations have made major investments in technology, advanced analytics / AI and myriad marketing initiatives. Too frequently, these investments aren't enough to overcome the market-driven challenges. The remedy for Chief Commercialization Officers: a sizable helping of wisdom from Taco Bell (and Nurtec) that translates into delicious results for those who follow the recipe and major indigestion for competitors.
- Align partners, assets and launch
- Realize market efficiencies through partnering
- Find disruptive approaches to team up
- Review key learnings in how to build your network
- Map out how to sell your strategy
- Prioritize building effective partnerships
Achieving forecast is a major measure of a successful launch for biopharmaceutical companies, but many factors play a role in reaching that goal. Successful launches require a strong product profile based on the clinical data, seamless cross functional coordination and understanding the sales and marketing resources required for the specific marketplace. In recent years, early integration of the patient voice has moved from a nice to include to a must have.
During this interactive session we will explore several scenarios where patient integration can play a critical factor for a launch success including:
- Understand the many ways patient perspectives support drug development, regulatory discussions and analysis to allow for the strongest go-to-market product label
- Discuss how the patient voice may impact decisions made for several scenarios including:
- launching in a rare disease market
- differentiating your approach for a new MOA product
- breaking through in competitive markets
- clarifying perspectives where misperceptions may pre-exist your launch.
- Balance demand with reimbursement
- Examine current reimbursement challenges
- Understand how payers evaluate new products
- Connect R&D, clinical and commercial personnel/teams
- Manage cultural change, enterprise readiness and harmony in the C-Suite
- Raise the profile of your company and products on the street and with the investor community